Stephanie Fowler

Stephanie Fowler is an accomplished professional in the pharmaceutical industry with extensive experience in sales and account management. Currently serving as a Key Account Manager for Rare Disease at Amylyx Pharmaceuticals since September 2023, Stephanie has previously held significant roles including Neurology Specialty Sales Representative at Amneal Pharmaceuticals from June 2018 to September 2023, and Pharmaceutical Sales Representative at Merck for the year 2017. Prior positions also include Specialty Pharmaceutical Sales Representative in Neurology at Aprecia Pharmaceuticals and Pharmacy Sales Specialist at Fresenius Medical Care. Stephanie holds a Bachelor's degree in Health Care Administration & Business from Ohio University.